Видео ютуба по тегу Thebiocenturyshow

The BioCentury Show: The Best of 2023
The BioCentury Show: The Best of 2023
Pharmas’ pandemic collaboration can and must continue: Plump on The BioCentury Show
Pharmas’ pandemic collaboration can and must continue: Plump on The BioCentury Show
Hope should not be passive: David Fajgenbaum on The BioCentury Show
Hope should not be passive: David Fajgenbaum on The BioCentury Show
Making Galapagos fit for survival: Stoffels on The BioCentury Show
Making Galapagos fit for survival: Stoffels on The BioCentury Show
Amy Schulman on the draw of Singapore, and more – The BioCentury Show
Amy Schulman on the draw of Singapore, and more – The BioCentury Show
The BioCentury Show: Interview with Aoife Brennan (Ep 73, Preview)
The BioCentury Show: Interview with Aoife Brennan (Ep 73, Preview)
Not every cycle is the same — Gilde’s Franken on The BioCentury Show
Not every cycle is the same — Gilde’s Franken on The BioCentury Show
Ep. 30 - Gilead's Merdad Parsey
Ep. 30 - Gilead's Merdad Parsey
ЧЕЛЛЕНДЖ НА ФАЭРБЁРД
ЧЕЛЛЕНДЖ НА ФАЭРБЁРД
Ep. 35 - Gilde's Arthur Franken
Ep. 35 - Gilde's Arthur Franken
Ep. 45 - Amicus' John Crowley
Ep. 45 - Amicus' John Crowley
The BioCentury Show: The Best of 2023
The BioCentury Show: The Best of 2023
Ep. 41 - Critical Path Institute's Klaus Romero
Ep. 41 - Critical Path Institute's Klaus Romero
Ep. 57 - BMS's Robert Plenge: Causal biology is the North Star of R&D
Ep. 57 - BMS's Robert Plenge: Causal biology is the North Star of R&D
Biocon’s path to affordable innovation
Biocon’s path to affordable innovation
How genomics will underpin GSK’s R&D era under Wood
How genomics will underpin GSK’s R&D era under Wood
Popular Episode - Bob Nelsen on AI, China and the IRA
Popular Episode - Bob Nelsen on AI, China and the IRA
Regulatory innovations will speed ultra-rare therapies, Marks says
Regulatory innovations will speed ultra-rare therapies, Marks says
FDA’s Cavazzoni on neuro, accelerated approval
FDA’s Cavazzoni on neuro, accelerated approval
Ep. 53 - Bob Nelsen on AI, China and the IRA
Ep. 53 - Bob Nelsen on AI, China and the IRA
Popular Episode - Vertex’s Winning Formula: Altshuler on Choosing the Next Breakthroughs
Popular Episode - Vertex’s Winning Formula: Altshuler on Choosing the Next Breakthroughs
Novartis CMO sees new FDA directives pushing biotechs to pharma deals
Novartis CMO sees new FDA directives pushing biotechs to pharma deals